Nashville Biosciences
Seth Belcher has a diverse work experience spanning multiple industries. Seth is currently working as a Business Development Manager at Nashville Biosciences since August 2019. Prior to this, they served as a Senior Account Executive at Gartner from September 2018 to March 2019. From August 2016 to August 2018, they worked at Counsyl as a Clinical Account Executive. Seth also has experience working at Thermo Fisher Scientific as a Clinical Sales Consultant from November 2012 to December 2016. Seth'searlier roles include serving as a Professional Sales Representative at Takeda from August 2007 to April 2012, as a Wholesale Account Executive at Lehman Brothers in 2007, and as a Wholesale Account Executive at Mortgage Lenders Network from 2006 to 2007.
Seth Belcher attended the University of Massachusetts Boston from 1998 to 2002. No specific degree or field of study information was provided.
This person is not in any offices
Nashville Biosciences
Nashville Biosciences, a wholly owned subsidiary of Vanderbilt University Medical Center, was created to harness the medical center's extensive genomic and bioinformatics resources for drug and diagnostics discovery and development. Leveraging Vanderbilt University Innovation™, Nashville Biosciences serves as a commercial interface between outside companies and the formidable research capabilities housed within Vanderbilt University Medical Center, including BioVU®, one of the world’s most comprehensive genetic databases linked to de-identified medical records with years of longitudinal clinical data. This unique asset is one of the largest and highest quality of its kind, providing an unprecedented opportunity to guide R&D activity in biotech, pharma, diagnostics, medical devices and other life sciences applications.